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Abstract 19 
The complement system is a critical part of teleost immune defences, with complement component 20 
C4 forming part of the classical and lectin pathways. Cod C4-like protein was isolated from plasma, 21 
specific antibodies generated and C4-like protein was assessed in cod sera, mucus and in 22 
extracellular vesicles (EVs) from serum and mucus. Higher levels of C4-like protein were detected in 23 
serum- than mucus-derived EVs. Post-translational deimination, caused by conversion of arginine 24 
into citrulline, can affect protein structure and function. Here we detected deiminated forms of C4-25 
like protein in cod serum and at lower levels in mucus. C4-like protein was also found in deiminated 26 
form at low levels in EVs from both serum and mucus. C4-like protein protein was assessed by 27 
immunohistochemistry in cod larvae and detected in a range of organs including in liver, kidney, gut, 28 
muscle, skin and mucus, as well as in neuronal tissues of the brain, spinal cord and eye. This 29 
abundance of C4-like protein during early development may indicate roles in tissue remodelling, in 30 
addition to immune defences. The presence of deiminated C4-like protein in serum and mucosa, as 31 
well as in EVs, may suggest C4 protein moonlighting via post-translational deimination.  32 
 33 
Highlights 34 
• Complement component C4-like protein is described for the first time in cod 35 
• C4-like protein is detected in serum, mucus, extracellular vesicles and a range of cod larval 36 
organs 37 
• Post-translational deimination of C4-like protein differs between serum and mucus 38 
• C4-like protein is exported in extracellular vesicles of serum and mucus at low levels 39 
• C4-like protein is exported in deiminated forms in EVs at low levels  40 
 41 
 42 
Key words: complement C4; protein deimination; extracellular vesicles (EVs); ontogeny; cod (Gadus 43 
morhua L.). 44 
 45 
  46 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
Introduction 47 
The complement system forms part of the first lines of immune defences against invading pathogens 48 
and participates in the clearance of necrotic and apoptotic cells (Dodds and Law, 1998; Fishelson et 49 
al., 2001; Hart et al., 2004; Carrol and Sim, 2011). Diverse roles of complement also include 50 
regeneration (Del-Rio-Tsonis et al., 1998; Haynes et al., 2013) and tissue remodelling during 51 
development (Lange et al., 2004a; 2004b; Lange et al., 2005; Lange et al., 2006). The complement 52 
pathway can be activated via the classical, alternative or lectin pathways, with all three pathways 53 
converging to form the C3 convertase, the downstream lytic pathway and the membrane attack 54 
complex (MAC), leading to killing of the microorganism (Dodds and Law, 1998; Sunyer and Lambris, 55 
1998; Volanakis, 2002; Dodds, 2002). The classical pathway is activated either via direct binding of 56 
C1 to acute phase proteins or proteins of bacterial and viral origin, or via the C1q subcomponent 57 
which can also bind to the Fc region of immunoglobulins that are bound to antigen (Reid et al., 2002; 58 
Reid, 2018). Downstream of C1 activation, C4 is cleaved and contributes to the formation of the C3 59 
convertase of the classical pathway. While C3 has previously been described in cod (Lange et al., 60 
2004a; 2004b; 2004c; 2005), C4 has hitherto not been studied in cod. 61 
Complement component C4 is a thioester containing glycoprotein composed of three disulphide 62 
linked chains;  α-, β- and ƴ-chains, which in human are 94, 72, and 30 kDa respectively, and is found 63 
in two isotypes which differ in the presence of a catalytic histidine (Dodds et al., 1996).  The 64 
presence of the two C4 isotypes has been verified in various jawed vertebrates including sharks, 65 
reptiles and birds (Nonaka et al., 2017).  In teleost fish, the structural and functional diversification 66 
of complement components has received considerable attention and is believed to contribute to 67 
balancing inflammatory and homeostatic processes (Sunyer and Lambris, 1998; Kuroda et al., 2000; 68 
Boshra et al., 2004; Boshra et al., 2006; Nakao et al., 2011).   69 
Previous studies from our group include ontogeny studies on complement component C3 in early 70 
teleost development (Magnadottir et al., 2004; Magnadottir & Lange 2004; Magnadottir et al., 2005; 71 
Lange et al., 2004a; Lange et al., 2004b; Lange et al., 2005, Lange et al., 2006; Magnadottir et al., 72 
2006) and on post-translationally deiminated proteins in teleost ontogeny and immunity 73 
(Magnadottir et al., 2018a and 2018b; Magnadottir et al., 2019a). Furthermore, recent work from 74 
our group has focussed particularily on extracellular vesicles and protein deimination both in teleost 75 
and elasmobranch species (Magnadottir et al., 2019b and 2019c; Criscitiello et al., 2019).  76 
Extracellular vesicles (EVs) are small lipid vesicles (30-1000 nm) which are released from cells and 77 
play roles in cell communication via transfer of a range of protein and genetic cargo. EVs are present 78 
in most body fluids and are widely studied in human health and disease, including for development 79 
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as biomarkers (Inal et al., 2013; Hessvik and Llorente, 2018). EV research is an emerging field in fish 80 
immunology, also for the development of usable biomarkers to assess fish health in response to 81 
environmental and immunological challenge (Iliev et al., 2018; Lagos et al., 2017; Magnadottir et al., 82 
2019b and 2019c).  83 
Post-translational deimination is caused by peptidylarginine deiminases (PADs), a phylogenetically 84 
conserved group of calcium catalysed enzymes which cause post-translational conversion of arginine 85 
into citrulline (Vossenaar et al., 2003; György et al., 2006). This causes structural, and sometimes 86 
functional, changes in target proteins (Witalison et al., 2015) and may also allow for protein 87 
moonlighting, facilitating proteins to take on a range of functions within one polypeptide chain 88 
(Jeffrey, 2018). We recently described novel roles for protein deimination in mucosal and innate 89 
immunity of teleost fish, including deimination of key immune factors (Magnadottir et al., 2018a; 90 
2018b; 2019a; 2019b; 2019c). 91 
 In the current study we set out to detect complement component C4 protein in early cod larval 92 
development, to assess putative post-translational deimination of C4 in cod serum and mucus and to 93 
confirm whether C4 forms part of EV cargo in serum and mucus. The findings of this study may shed 94 
new light on functional diversity of C4-like protein in cod.  95 
 96 
2. Materials and Methods 97 
2.1 Fish and sampling 98 
Experimentally farmed adult cod (Gadus morhua L) and larvae were obtained from the Marine 99 
Institute’s Experimental Fish farm Stadur, Grindavik, Iceland; reared as described before (Lange et 100 
al., 2004a; Magnadottir et al., 2018a).  For isolation of C4, fish blood (5-10 ml) was collected into 101 
ethylene-diamine-tetra-acetic (EDTA)-coated syringes (Monovette, Germany) from the caudal vein 102 
of 20 adult cod. The blood was placed on ice for 2 h and plasma was collected by centrifuging at 750 103 
g for 10 min. The samples from individual fish were pooled and stored at 4 °C in the presence of 5 104 
mM EDTA until used. Human citrated plasma was obtained from HD Supplies (Aylesbury, U.K.) and 105 
EDTA added to a final concentration of 10 mM before use. For preparation of sera, collected blood 106 
was allowed to clot overnight at 4 °C and serum was collected after centrifuging at 750 g for 10 min, 107 
divided into aliquots and stored at -80 °C until used. Mucus was collected and prepared from adult 108 
cod as previously described (Magnadottir et al., 2018a). Cod larvae were collected during the 109 
spawning season (April-June) as previously described (Lange et al., 2004a), and for this study two age 110 
stages, 28 and 57 days post hatching (d.p.h), were used to assess C4 protein detection in tissues and 111 
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organs, using longitudinal sections through the whole larvae. Four larvae were used for each 112 
sampling date, fixed in 4 % formalin in phosphate buffered saline (PBS) at 4 °C for 24 h and 113 
thereafter embedded in paraffin and stored at room temperature until used.  114 
2.2 Cod C4 isolation and antibody generation 115 
Human C4 was prepared as described by Dodds (1993) and used as a standard during the 116 
purification of cod C4 protein, which was purified using the same method. C4-like protein was 117 
isolated from cod plasma by column chromatography using Q-Sepharose HP, followed by MonoQ 118 
and Superdex 200 (HR 10/30) (Amersham Biosciences) gelfiltration columns, after initial 119 
precipitation by 5 % PEG (polyethylene glycol) (Dodds, 1993). Purified cod C4-like protein fractions 120 
(cod-C4) were compared to human C4 (Hu-C4) and separated under reducing conditions respectively 121 
on a 10 % polyacrylamide gel and Coomassie blue stained (Fig. 1A). The purified fractions were 122 
subjected to N-terminal sequence analysis using cut-out bands (performed in-house by Anthony 123 
Willis, MRC Immunohistochemistry Unit Oxford), using the Applied Biosystems 470A/120A protein 124 
sequencer as previously described (Crawford et al., 1990). N-terminal analysis of both C4α- and β-125 
chains from cod C4-like protein was compared to other species, using Clustal Omega 126 
(https://www.ebi.ac.uk/Tools/msa/clustalo/) and protein sequences from human (Homo sapiens; 127 
AAB59537.1), Xenopus (Xenous laevis; AAI70420.1), nurse shark (Ginglymostoma cirratum; 128 
AAY55950.1), channel catfish (Ictalurus punctatus; XP_017326706.1), carp (Cyprinius carpio; 129 
XP_018973374.1, BAB03284.1) and Japanese medaka (Oryzias latipes; NP_001098167.1) (Fig. 1B). 130 
Polyclonal anti-cod C4-protein like antibodies were produced in mouse ascetic fluid according to the 131 
method of Overkamp et al. (1988), as previously described for cod C3 (Lange et al., 2004c). Ascetic 132 
fluid was collected, aliquoted and stored at -80 °C. The specificity of the anti-cod C4-protein like 133 
antibody was tested on purified cod C4 (Fig. 1B) and on cod serum (Fig. 2A).  134 
2.3 Extracellular vesicle isolation from mucus and serum 135 
EVs were isolated from cod sera and mucus using step-wise centrifugation. First, serum and mucus 136 
were diluted 1:4 and 1:5 respectively, in sterile filtered Dulbecco’s phosphobuffered saline (DPBS), 137 
adding 250 μl serum to 750 μl DPBS, or 200 μl of mucus to 800 μl DPBS, respectively. These were 138 
centrifuged at 4,000 g for 30 min at 4 °C to remove cell debris and aggregates, and thereafter the 139 
supernatant was collected and ultracentrifuged at 100,000 g for 1 h at 4 °C. The obtained EV pellets 140 
were resuspended and washed in sterile DPBS, ultracentrifuged again at 100,000 g for 1 h at 4 °C 141 
and the resulting EV pellets were solubilised in 50 µl DPBS and subjected to nanoparticle tracking 142 
analysis (NTA) and protein extraction for immunoprecipitation and for Western blotting. 143 
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2.4 Characterisation of EVs  144 
EVs were characterised using NTA, Western blotting and transmission electron microscopy (TEM). 145 
For NTA analysis, the individual EV pellets derived from 250 μl of serum or 200 μl of mucus 146 
respectively, per sample, were resuspended in 50 μl DPBS and diluted 1/200 in DPBS. EVs were 147 
assessed for size distribution based on Brownian motion, using the NanoSight NS300 (Malvern, U.K.). 148 
Samples were applied to the NanoSight using a syringe pump to ensure even flow of the sample, 149 
with numbers of particles in the window at 40 - 60 per frame. Videos were recorded for 5 x 60 sec 150 
and the histograms generated from the individual repetitive reads were averaged. EVs were tested 151 
by Western blotting for CD63 and Flotillin-1, which are EV-specific markers conserved in bony fish 152 
(Iliev et al., 2018).  For TEM, EVs were fixed with 2.5 % glutaraldehyde in 100 mM sodium cacodylate 153 
buffer (pH 7.0) for 1 h at 4 °C, resuspended in 100 mM sodium cacodylate buffer (pH 7.0), placed on 154 
to a grid with a glow discharged carbon support film and stained with 2 % aqueous Uranyl Acetate 155 
(Sigma-Aldrich) (Supplementary Fig. 1). 156 
2.5 Immunoprecipitation 157 
Total deiminated proteins were isolated by immunoprecipitation from a pool of sera, a pool of 158 
mucus protein extract, or EVs from both, respectively. Immunoprecipitation was performed using 159 
the Catch and Release® v2.0 Reversible Immunoprecipitation System (Merck, U.K.) according to the 160 
manufacturer’s instructions, and the monoclonal F95 pan-deimination antibody (MABN328, Merck), 161 
which specifically recognises deiminated proteins (Nicholas and Whitaker, 2002). F95-bound 162 
proteins were eluted under reducing conditions, according to the manufacturer’s instructions, and 163 
diluted 1:1 in 2x Laemmli sample buffer for Western blotting analysis. 164 
2.6 Western blotting 165 
Protein samples prepared from cod C4-like protein fractions, sera, mucus, EVs and the 166 
corresponding F95-bound eluates were analysed by Western blotting for detection of C4-like 167 
protein. Approximately 5 μg of protein sample was loaded per lane, even load was assessed using 168 
Ponceau S staining (Sigma, U.K.), membranes were thereafter blocked in 5 % bovine serum albumin 169 
(BSA) in Tris buffered saline with 0.1% Tween20 (TBS-T) for 1 h, followed by incubation at 4 °C 170 
overnight with the primary anti-C4 protein-like antibody (1/1000; in TBS-T). EV specific markers used 171 
for EV characterisation were CD63 (ab216130, 1/1000) and Flot-1 (ab41927, 1/2000). Following 172 
primary antibody incubation, membranes were washed 3 times in TBS-T, incubated at room 173 
temperature for 1 h with HRP-conjugated secondary antibodies (anti-mouse IgG or anti-rabbit IgG; 174 
BioRad, U.K.), followed by 6 washes in TBS-T before visualisation using ECL (Amersham, U.K.) and the 175 
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UVP BioDoc-ITTM System (U.K.). For Fig. 1, Western blots were developed using alkaline 176 
phosphatase conjugated secondary mouse-IgG (Dako, Denmark) and 0.1 M ethanolamine/HCl buffer 177 
(pH 9.6) containing NBT (1 mg ml−1p-nitroblue tetrazolium), 0.1 M MgCl2 and BCIP (4 mg ml−15-178 
bromo-4chloro-indolyl phosphate in methanol:acetone (2:1).   179 
2.7 Immunohistochemistry 180 
For immunohistochemistry, 5 micron serial tissue sections were cut on a microtome to detect the 181 
presence of C4-like protein in cod larvae at two developmental stages, at 28 d.p.h., for an earlier 182 
stage, and 57 d.p.h. when cod larvae have reached immunocompetence (Magnadottir et al., 2005). 183 
Tissue sections were deparaffinised using xylene, taken to water (100%, 90%, 70% ethanol) and de-184 
masked by heating (12.5 min in the microwave at power 8) in citric acid buffer (pH 6.0). Thereafter 185 
the sections were washed in 0.1 % BSA in 100 mM phosphate buffer (PB) and washed two times in 186 
PB. Next the sections were incubated with 5 % goat serum (Sigma, St. Louis, MO, USA) in PB for 1 h, 187 
followed by incubation in the anti-cod C4 primary antibody, diluted 1/100 in PB/BSA at 4 °C 188 
overnight. The sections were thereafter washed for 2 min in serial washes of PB/BSA, PB, PB and 189 
PB/BSA, and incubated with biotin-labelled anti-mouse IgG (1/200; Vector Laboratories, Inc., 190 
Burlingame, CA, USA). Visualisation was performed using Avidin-Biotinylated peroxidase Complex 191 
(ABC, Vector Laboratories, Inc.) and diaminobenzidine/hydrogen peroxide (DAB) stain (Vector 192 
Laboratories). Sections were counterstained with Mayer’s Haematoxylin (Sigma, U.K.), dehydrated in 193 
alcohol, immersed in xylene and mounted with DEPEX (Sigma).  Four larvae for each developmental 194 
stage were analysed. 195 
 196 
3. Results 197 
3.1 C4 isolation and antibody generation 198 
Cod C4-like protein was isolated from 20 ml of pooled EDTA plasma, using PEG precipitation and 199 
purification on Q-Sepharose HP, followed by MonoQ and Superdex 200 (HR 10/30) gelfiltration 200 
columns. The purified cod C4 fractions were analysed by SDS-PAGE and Coomassie blue staining and 201 
found to have a three chain structure, similar to human C4 (Fig. 1A). For purified cod C4-like protein, 202 
the approximately 90 and 68 kDa bands are consistent with the C4 α- and β-chains respectively, 203 
while the band below 37 kDa is indicative of the ƴ-chain. The 250 kDa band corresponds to PRO-C4, 204 
i.e. the form of C4 that has not been cleaved to form 3 chains. Other bands may represent α-chain 205 
fragments (α-f), including smaller bands below the β-chain. The 250 kDa band corresponds to PRO-206 
C4, i.e. the form of C4 that has not been cleaved to form 3 chains. Other bands may represent alpha 207 
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chain fragments, including smaller bands below the β-chain. N-terminal amino acid sequencing was 208 
performed of both the C4α- and β- chains and the resulting sequences were aligned with 209 
corresponding sequences from other species throughout phylogeny (Fig. 1B). The C4 sequences from 210 
the following species are shown for comparison: human (Homo sapiens; AAB59537.1), Xenopus 211 
(Xenous laevis; AAI70420.1), nurse shark (Ginglymostoma cirratum AAY55950.1), channel catfish 212 
(Ictalurus punctatus;  XP_017326706.1), carp (Cyprinius carpio; XP_018973374.1, BAB03284.1) 213 
and Japanese medaka (Oryzias latipes; NP_001098167.1) (Fig. 1B). Polyclonal antibodies, produced 214 
against the whole cod C4-like protein in mouse ascetic fluid, were confirmed to react with the 215 
purified C4 fractions (Fig. 1C) and showed positive for all three C4 chains (α-, β- and γ-chains), as well 216 
as α-chain fragments (α-f), in cod serum and mucosa (Fig. 2B).  217 
3.2 C4 detection in serum, mucus and extracellular vesicles (EVs). 218 
Cod C4-like protein was detected in serum and mucus, at similar levels (Fig. 2A). EVs isolated from 219 
cod serum and mucus (Supplementary Fig 1) were assessed for C4 cargo. In serum-derived EVs, C4-220 
like protein was found at higher levels compared to EVs isolated from mucus (Fig. 2A). 221 
3.3 C4-like protein deimination varies between serum and mucus 222 
To identify if C4-like protein was post-translationally deiminated, the F95-bound eluates, from serum 223 
and mucus respectively, were probed with the anti-cod C4-like protein antibody. The C4-like protein 224 
antibody was found to react with the F95 eluate of both serum (Fig. 2B) and mucus (Fig. 2C), albeit 225 
with some differences. In serum, bands representative of C4 were stronger deimination positive, 226 
while in mucus only very low levels of C4-like protein showed deimination positive. In EVs derived 227 
from serum and mucus, the F95 eluate showed some low positive for C4 (Fig. 2D).  228 
3.4. C4 immunohistochemistry in cod larvae 229 
Using immunohistochemistry, longitudinal tissue sections of larval stages of cod aged 28 and 57 days 230 
post hatching (d.p.h.) were assessed for tissue distribution of C4-like protein. A similar pattern of C4-231 
like protein detection was found at these two stages of development.  C4-like protein was 232 
detectable in immune organs including liver, where hepatocytes were strongly C4 positive (Fig. 3A), 233 
and in kidney, where both glomeruli and tubuli were strongly C4-like protein positive (Fig. 3B). In 234 
gut, C4-like protein was strongly detected in mucosa (Fig. 3C), in gill mucosa and chondrocytes (not 235 
shown), as well as in skin mucosa and in muscle (Fig. 3D). C4-like protein was also seen in mucosa of 236 
the mouth and oesophagus (not shown) as well as in chondrocytes (not shown). C4-like protein was 237 
clearly detected in neuronal tissues including in brain (Fig. 3E) and spinal cord (not shown) as well as 238 
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in the eye, with C4-like protein positive cells in the inner and outer ganglion layers, and plexiform 239 
layers (Fig. 3F). 240 
4. Discussion 241 
Complement component C4-like protein is here described for the first time in Atlantic cod (Gadus 242 
morhua L.). C4-like protein was found in serum and mucus at similar levels, indicating roles in the 243 
immune defence at these sites. Extracellular vesicles (EVs) were assessed for C4 protein cargo, which 244 
was more abundant in EVs from sera than mucus.  For the first time, deiminated forms of C4-like 245 
protein were identified in cod serum and mucus. Post-translationally deiminated C4-like protein was 246 
detected in serum and mucus and C4-like protein was found to be exported in deiminated forms at 247 
low levels in both serum and mucus derived EVs. In comparison, C3 was recently reported at high 248 
levels in EVs from both mucus and serum, including in deiminated form (Magnadottir et al., 2019b 249 
and 2019c), indicating marked differences in EV-mediated export of these two complement 250 
components. 251 
Post-translational deimination is a means of increasing antigenic diversity via changes in protein 252 
structure and folding, leading to altered antigen processing, antigen presentation and immune 253 
recognition (Doyle and Mamula, 2012). These changes can for example alter interaction with 254 
immune cells and also affect signalling pathways (Nguyen and James, 2016). Deimination of C4-like 255 
protein, observed here in cod serum and mucus, may indicate a mode for functional diversity of C4 256 
at these sites, and possibly influence its ability for cleavage and formation of the classical pathway 257 
C3 convertase. Indeed, pharmacological inhibitors of deimination have been shown to ameliorate 258 
collagen-induced arthritis via decreased complement deposition in synovium and cartilage (Willis et 259 
al., 2011; Willis et al., 2017). A similar phenomenon of post-translational deimination of C4 as seen 260 
here in cod C4-like protein, was recently identified in a range of complement factors, including C3 261 
and C4 (Magnadottir et al., 2019a). 262 
Here we report C4-like protein detection in a range of immune-related, neuronal and mucosal 263 
tissues in early cod ontogeny. This is a similar pattern as previously observed for complement 264 
component C3 in cod larvae (Lange et al., 2004a; 2005). C4 protein was high in liver, which is the 265 
main site of complement synthesis, as well as in a range of other organs. C4 was strongly detected in 266 
kidney, both in tubuli as well as in glomeruli, which are known sites of complement component 267 
synthesis (Morgan and Gasque, 1997) and also previously shown to synthesise C3 in cod (Lange et 268 
al., 2004a; 2005). C4 was strongly detected in mucosal surfaces of the skin, gut, as well as in gills. 269 
This is in line with the importance of the alimentary tract, gut, gills and mucosal surfaces on the 270 
epidermis for fish immune defences (Ellis, 2001; Parra et al., 2015; Gomez et al., 2013).  Intestinal 271 
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cells are known to be local production sites for complement components, including C4 (Andoh et al., 272 
1993; Laufer et al., 2000). In neuronal tissue, C4 protein was seen at high levels in spinal cord, brain 273 
and eye, similar to as previously observed for cod C3 (Lange et al., 2004a; 2005), and may indicate 274 
roles in tissue remodelling during ongoing neurogenesis at these sites (Barnum et al., 1995; Morgan 275 
and Gasque, 1996; Terai et al., 1997). As the complement system participates in apoptotic processes, 276 
phagocyte recruitment and opsonisation of apoptotic cells (Fishelson et al., 2001; Hart et al., 2004), 277 
C4 may contribute to homeostatic roles of the complement system in tissue remodelling during 278 
development (Cole and Morgan, 2003; Lange et al., 2005; Magnadottir et al., 2019a). Furthermore, 279 
C4-like protein deimination in mucus and serum suggests temporal and spatial changes in C4 post-280 
translational modification to facilitate diverse functions of C4, according to environmental 281 
requirements. In comparison, halibut C4 was also recently identified to be deiminated in serum 282 
(Magnadottir et al., 2019a), further indicating functional diversity of C4 via deimination which 283 
remains to be further investigated throughout phylogeny.  284 
The findings presented in the current study provide novel insights into putative moonlighting 285 
functions of C4 in immunity, during development and in the maintenance of homeostasis. 286 
 287 
Conclusions 288 
Complement component C4-like protein is here described for the first time in Atlantic cod (Gadus 289 
morhua L.) and found to be post-translationally deiminated in mucus and serum, indicative of 290 
functional diversity. Extracellular vesicles ( Vs) were found to contain C4 protein cargo, which was 291 
more abundant in EVs from sera than mucus. Furthermore, deiminated C4 was also observed in EVs 292 
at low levels.  C4-like protein was detected in early cod ontogeny in a range of organs, indicative of 293 
roles in immune defences and tissue remodelling during larval development. C4 may, through post-294 
translational deimination, take on diverse functions to meet temporal and spatial requirements in 295 
host defence and maintenance of homeostasis.  296 
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Figure legends. 455 
Fig. 1. C4 isolation from cod plasma. A. Purified cod C4 fractions isolated from cod plasma (cod-C4) 456 
by  column chromatography are shown compared to purified human C4 isolated from human plasma 457 
(Hu-C4) and separated under reducing conditions on a 10 % polyacrylamide gel and Coomassie blue 458 
stained. The C4α-, β-, and γ- chains are indicated. The approximately 90 and 68 kDa bands are 459 
consistent with the C4 α- and β-chains respectively, while the band below 37 kDa is indicative of the 460 
ƴ-chain. The 250 kDa band corresponds to PRO-C4, i.e. the form of C4 that has not been cleaved to 461 
form 3 chains. Other bands may represent α-chain fragments (α-f), including smaller bands below 462 
the β-chain. B. The purified C4 fractions were assessed by N-terminal analysis and compared to C4 463 
from other species to verify identification of cod C4. Conserved amino acids throughout phylogeny 464 
are underlined and phylogenetic clustering for the C4-like protein α- and β-chains is shown. 465 
Sequences used were: human (Homo sapiens; AAB59537.1), Xenopus (Xenous laevis; AAI70420.1), 466 
nurse shark (Ginglymostoma cirratum AAY55950.1), channel catfish (Ictalurus punctatus; 467 
XP_017326706.1), carp (Cyprinius carpio; XP_018973374.1, BAB03284.1) and Japanese medaka 468 
(Oryzias latipes; NP_001098167.1, XP_024115560.1).  C. Polyclonal mouse anti-cod C4-like protein 469 
antibody was produced and tested on the C4-like protein fractions. 470 
Fig. 2. C4 detection in serum and mucus and verification of deiminated C4. A. Western blotting 471 
showing C4 in serum, mucus and in EVs isolated from serum and mucus, respectively. C4 is strongly 472 
detected in both serum and mucus, and at higher levels in EVs of serum than mucus. The C4 α- β- 473 
and ƴ-chains are indicated as well as α-chain fragment (α-f). B. Deiminated C4 is detected in serum, 474 
by assessing the F95-enriched eluate (which was obtained by IP from cod serum using the pan-475 
deimination F95 antibody) against the C4 antibody. The C4 β- and ƴ-chains are indicated. C. 476 
Deiminated C4 is hardly detectable in mucus, by assessing the F95-bound eluate against the C4 477 
antibody. A faint band representative of the C4 β-chain is visible as well as a very faint band in the γ-478 
chain region, but at much lower levels than what is seen in serum (see B). D. Deiminated C4 was 479 
detected at very low levels in EVs from serum and mucus, by blotting the F95-bound eluate against 480 
the C4 antibody. C4 β- and γ-chains are indicated.  481 
Fig. 3. Histology of C4-like protein in cod larvae. A. Liver (28 d.p.h.): hepatocytes are strongly C4 482 
positive; B. Kidney (28 d.p.h.): glomerulus (gl) and tubuli (tub) are strongly C4 positive and indicated 483 
by arrows; C. Gut (28 d.p.h.): mucosal cells are strongly C4 positive; D. Skin (sk), skin mucosa (mu) 484 
and muscle (mus) are C4 positive (57 d.p.h.); E. Neurones in brain show strong C4 positive (57 485 
d.p.h.); F. In eye (7 d.p.h.) the plexiform (pl), outer ganglion (og) and inner ganglion (ig) layers are 486 
strongly C4 positive.  The scale bars indicate 100 μm in all figures.  487 
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Supp. Fig. 1. EV isolation and characterisation from serum and mucus. A. Serum and mucosal EVs 488 
were characterised by nanoparticle tracking analysis (NTA) and a representative histogram shows a 489 
typical polydispersed population of EVs falling mainly between 30-400 nm in size; B. Western 490 
blotting of EVs from serum and mucus, respectively, for the EV-specific markers Flot-1 and CD63; C. 491 
Transmission electron microscopy (TEM) of serum and mucosal EVs (scale bar = 200 nm).  492 
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